Generic drug of the therapeutic class: Dermatology
active ingredients: Betamethasone, Salicylic acid
laboratory: Meda Pharma
30 g tube
Corticosensitive dermatoses with keratotic or squamous component:
1. Preferred indications where local corticosteroid therapy is held for the best treatment:
2. Indications where corticosteroid therapy is one of the usual treatments:
- psoriasis (excluding large plaque psoriasis),
- lichen plan,
- dry or lichenified eczemas,
- palmoplantar keratoderma.
Dosage BETNESALIC Ointment Tube of 30 g
- Two applications a day followed by a light massage, for one to two weeks. An increase in the number of daily applications could aggravate the adverse effects without improving the therapeutic effects.
- If no improvement has been observed at the end of treatment, the diagnosis must be reconsidered and specialized consultation may be necessary.
- The treatment of large surfaces requires special monitoring (number of tubes used).
- Some dermatoses (psoriasis, ...) make it desirable to stop gradually. It can be obtained by reducing the frequency of applications and / or by using a less strong or less dosed corticosteroid, and / or alternating with a base without a corticoid.
- Hypersensitivity to any of the components contained in the preparation.
- Viral dermatoses: shingles, herpes, varicella, vaccinia.
- Primitive or parasitic bacterial or fungal infections, even if they have an inflammatory component.
- Ulcerated lesions, oozing lesions.
- Acne, rosacea and perioral dermatitis.
- Dermatoses of children under one year old.
- Betnesalic is not intended for ophthalmic use or application to the eyelids or mucous membranes.
Betnesalic side effects
- Prolonged use under occlusion can lead to skin atrophy, telangiectasia (to be feared especially on the face), stretch marks (at the root of the limbs in particular, and occurring more readily in adolescents), ecchymotic purpura secondary to atrophy, fragility. cutaneous.
- Can be observed delayed healing of sluggish wounds, pressure ulcers and leg ulcers (see contraindications).
- On the face, corticosteroids can create peri-oral dermatitis, or create or aggravate rosacea (see warnings and contraindications).
- Irritation, dryness, folliculitis and acneiform rash, more rarely hypertrichosis and depigmentation have been reported with all highly active corticosteroids used in local application.